(Q36474467)

14 August 2017

Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma (English)

1 reference

14 August 2017

hepatocellular carcinoma

1 reference

10

Giacomo Zanus

1 reference

14 August 2017

Davide Francesco D'Amico

13

object named as

Davide Francesco D'Amico

1 reference

14 August 2017

Umberto Cillo

1

1 reference

14 August 2017

Alessandro Vitale

2

1 reference

14 August 2017

Filippo Navaglia

3

1 reference

14 August 2017

Daniela Basso

4

1 reference

14 August 2017

Umberto Montin

5

1 reference

14 August 2017

Marco Bassanello

6

1 reference

14 August 2017

Francesco D'Amico

7

1 reference

14 August 2017

Francesco Antonio Ciarleglio

8

1 reference

14 August 2017

Alberto Brolese

9

1 reference

14 August 2017

Vito De Pascale

11

1 reference

14 August 2017

Mario Plebani

12

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

World Journal of Gastroenterology

14 August 2017

1 reference

14 August 2017

11

1 reference

14 August 2017

44

1 reference

14 August 2017

6920-6925

1 reference

Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma.

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Does surgical resection of hepatocellular carcinoma accelerate cancer dissemination?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

The prognostic molecular markers in hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Hepatocellular carcinoma: diagnosis and treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Is surgery for large hepatocellular carcinoma justified?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Prognosis of hepatocellular carcinoma: the BCLC staging classification

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Transection of the oesophagus for bleeding oesophageal varices

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?

21 September 2018

1 reference

12 December 2020

Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma

1 reference

12 December 2020

Simplified staging for hepatocellular carcinoma

1 reference

12 December 2020

Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver

1 reference

12 December 2020

Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery

1 reference

12 December 2020

Postoperative detection of alpha-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma

1 reference

12 December 2020

Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma

1 reference

12 December 2020

Prognosis after hepatic resection for stage IVA hepatocellular carcinoma: a need for reclassification

1 reference

12 December 2020

Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation

1 reference

12 December 2020

Multimodal approach and its impact on survival for patients with hepatocellular carcinoma

1 reference

12 December 2020

Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V11.I44.6920

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

16437593

1 reference